Fri.Mar 19, 2021

article thumbnail

Three drugmakers nab $639M as biotech's IPO pace eclipses a record year

Bio Pharma Dive

Nineteen biotechs have now gone public in the first quarter of 2021, raising a combined $3.6 billion and continuing a surge that began during the coronavirus pandemic.

265
265
article thumbnail

Value-Based healthcare won’t work

World of DTC Marketing

SUMMARY: Value-based healthcare is a healthcare delivery model in which providers, including hospitals and physicians, are paid based on patient health outcomes. Under value-based care agreements, providers are rewarded for helping patients improve their health, reduce the effects and incidence of chronic disease, and live healthier lives in an evidence-based way.

Doctors 143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

With new results, Sarepta's 2nd gene therapy holds steady

Bio Pharma Dive

Stung by a clinical trial miss in Duchenne muscular dystrophy, the biotech now has promising, if early, data to back a gene therapy for a different rare neuromuscular disease.

article thumbnail

DeepVerge’s nanochip-based COVID breath test could be ready this year

pharmaphorum

DeepVerge has announced trial data showing its COVID-19 Microtox BT breath test can deliver accurate results in under 60 seconds, with a potential roll-out later this year if further tests support it. The company has already completed of the system that resembles a breathalyser in phase 1 and phase 2 studies with the SARS-CoV-2 virus in the safety of laboratories.

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

How our microplastic waste becomes ‘hubs’ for pathogens, antibiotic-resistant bacteria

Scienmag

A new study shows how microplastics found in our daily personal care products can also host pathogens and boost antibiotic-resistant bacteria by up to 30 times once they wash down household drains and enter municipal wastewater treatment plants Credit: NJIT It’s estimated that an average-sized wastewater treatment plant serving roughly 400,000 residents will discharge up […].

Bacteria 104
article thumbnail

Could a smartphone cough app stop future pandemics?

pharmaphorum

A host of companies are looking at cough apps to detect the presence of COVID-19. But one company called Hyfe wants to take the idea a step further and use them to detect future pandemics, reports Richard Staines. . The pandemic has seen a plethora of digital tools emerge to help manage patients remotely, with the ubiquitous use of smartphone technology allowing medics to monitor patients’ vital signs without risky face-to-face contact.

Marketing 122

More Trending

article thumbnail

Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies

pharmaphorum

This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on.

115
115
article thumbnail

How flashlight fish communicate with light signals in the school

Scienmag

The blinking frequency affects the behaviour of the other fish in the school. Credit: RUB, Department of General Zoology and Neurobiology, Stefan Herlitze Flashlight fish have the ability to generate situation-specific blink patterns resembling a visual Morse code. Researchers at Ruhr-Universität Bochum have shown in laboratory and field experiments that the animals use these light […].

article thumbnail

Protein misfolding specialist Gain nets $40m from IPO

pharmaphorum

Gain Therapeutics has priced its initial public offering, raising more than $40 million for its computational drug discovery platform and pipeline of drugs for diseases associated with protein misfolding. . The shares began trading on the Nasdaq yesterday under the symbol ‘GANX’, closing at $11.20 and valuing the company at around $130 million. Bethesda, Maryland-headquartered Gain, which was originally formed in Switzerland, is focusing initial on lysosomal storage disorders (LSDs), a group of

Protein 95
article thumbnail

For good health, trust your gut

Scienmag

UC chemist uses federal grant to study brain-immune system communication Credit: Ravenna Rutledge/UC Creative If it seems like your stomach has a mind of its own, you’re not wrong. University of Cincinnati assistant professor Ashley Ross says your body is full of neurons that regulate digestion, inflammation and a host of other biological processes.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

NICE backs ovarian cancer and multiple myeloma combination drugs

pharmaphorum

NICE has recommended funding for two cancer drug combinations for ovarian cancer and multiple myeloma. In final draft guidance that applies to England, NICE said AstraZeneca/MSD’s Lynparza (olaparib) plus Roche’s Avastin (bevacizumab) should be reimbursed by the Cancer Drugs Fund in people with ovarian cancer that have responded to platinum chemotherapy.

Drugs 94
article thumbnail

City of Hope celebrates earning one of nursing’s highest honors

Scienmag

The prestigious Magnet® recognition from the American Nurses Credentialing Center highlights City of Hope’s world-class nursing team and their superior level of compassionate patient care Credit: City of Hope DUARTE, Calif. — City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, and its nursing team have achieved […].

Nurses 96
article thumbnail

UK and EU regulators reaffirm the safety of AZ/Oxford Uni’s COVID-19 vaccine

Pharma Times

MHRA and EMA conclude the vaccine's benefits continue to outweigh risks

article thumbnail

Tiny machine poised to unlock brain’s mysteries

Scienmag

Novel device records, senses and manipulates ‘mini-brains’ Credit: Northwestern University A team of scientists, led by researchers at Northwestern University, Shirley Ryan AbilityLab and the University of Illinois at Chicago (UIC), has developed novel technology promising to increase understanding of how brains develop, and offer answers on repairing brains in the wake of neurotrauma and […].

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

EU authorisation for XPhyto’s rapid COVID-19 PCR test

Pharma Times

PCR-based test has a sample collection to result time of 25 minutes

118
118
article thumbnail

LSU Veterinary School receives $11M COBRE grant for a pre-clinical cancer research center

Scienmag

Credit: LSU The Louisiana State University School of Veterinary Medicine, or LSU SVM, has received an $11 million grant to establish a Center of Biomedical Research Excellence, or COBRE. The COBRE funds will create the Center for Pre-Clinical Cancer Research, or Cancer COBRE, which will be based at the LSU SVM. This grant will last […].

article thumbnail

ICR’s ‘resistance-busting’ drug advances into Phase I trial

Pharma Times

EP0042 is a dual-inhibitor drug designed to block the activity of two cancer-driving proteins

Drugs 104
article thumbnail

CU cancer researcher wins two awards to study drug-resistant cancer cells

Scienmag

University of Colorado Boulder researcher Sabrina L. Spencer, PhD., recently won the Damon Runyon-Rachleff Innovation Award (from the Damon Runyon Cancer Research Foundation) and the Emerging Leader Award (from The Mark Foundation for Cancer Research) Credit: Sabrina Spencer Sabrina L. Spencer, PhD, is a CU Boulder researcher and a CU Cancer Center member.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Red Havas launches ‘global health micro-network’

pharmaphorum

Red Havas has announced the launch of Red Havas Health, a global micro-network focused on health, in response to increasing demand from clients globally. The new offering brings together health professionals from Red Havas across the US, Australia, Singapore, Vietnam and the Philippines, as well as Havas Health PR in New York, Havas Life Medicom PR based in the UK and Havas PR in Milan.

article thumbnail

Endocrine disruptors threatens semen quality

Scienmag

Scientists from UNIGE and IRSET have established a link between poor semen quality in adult men and their mothers’ occupational exposure to endocrine disruptors during pregnancy. Credit: © UNIGE A growing number of studies show that the environmental factors and lifestyle habits of pregnant women play an important role in the health of their child. […].

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of

article thumbnail

Better batteries start with basics — and a big computer

Scienmag

UC chemists used quantum simulations to understand a solvent that holds promise for green energy Credit: Colleen Kelley/UC Creative To understand the fundamental properties of an industrial solvent, chemists with the University of Cincinnati turned to a supercomputer. UC chemistry professor and department head Thomas Beck and UC graduate student Andrew Eisenhart ran quantum simulations […].

91
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

NICE approves Lynparza plus Avastin via Cancer Drugs Fund

Pharma Times

Genomic HRD testing to be launched to support the introduction of this treatment regimen

Genome 74
article thumbnail

UNIST signs MoU with Ulsan Metropolitan City to promote digital new deal in Ulsan!

Scienmag

Credit: UNIST UNIST and Ulsan Metropolitan City have embarked on an effort to successfully promote the Digital New Deal in Ulsan region. On February 4, a ceremony to mark the signing of a Memorandum of Understanding (MoU) between UNIST and Ulsan Metropolitan City took place at the AI Innovation Park, located in Duwang-dong, Nam-gu, Ulsan. […].

article thumbnail

What to Include in the Clinical Trial Study Close-out Checklist

Cloudbyz

Study close-out is an essential factor in a clinical trial study. This process ensures that all the clinical trial activities are rightly reconciled, recorded, and reported at the end of the study trial. Usually, a study trial is considered closed by clinical research companies when the study report is finalised and the database is locked. Why is study close-out important?

article thumbnail

Bioengineers learn the secrets to precisely turning on and off genes

Scienmag

Credit: Thomas Gorochowski In a recent study led by the University of Bristol, scientists have shown how to simultaneously harness multiple forms of regulation in living cells to strictly control gene expression and open new avenues for improved biotechnologies. Engineered microbes are increasingly being used to enable the sustainable and clean production of chemicals, medicines […].

Gene 75
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

New patent expiration for Recordati Rare drug NEOPROFEN

Drug Patent Watch

Annual Drug Patent Expirations for NEOPROFEN Neoprofen is a drug marketed by Recordati Rare and is included in one NDA. It is available from two suppliers. There are three patents…. The post New patent expiration for Recordati Rare drug NEOPROFEN appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Parkinson’s disease: When molecular guardians need to be protected

Scienmag

Credit: Nicola Roverato, University of Konstanz Parkinson’s disease is the second most common, age-related, neurodegenerative disease: In Germany alone, about 300,000 people are affected and experience sometimes major limitations to their quality of life. Although Parkinson’s is so widespread, there is still no treatment that targets the cause of the disease and can stop it […].

article thumbnail

New patent for Teva Branded drug PROAIR DIGIHALER

Drug Patent Watch

Annual Drug Patent Expirations for PROAIR+DIGIHALER Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are…. The post New patent for Teva Branded drug PROAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

New findings about immune system reaction to malaria and sickle cell disease

Scienmag

Scientists have discovered in more detail than ever before how the human body’s immune system reacts to malaria and sickle cell disease. Scientists have discovered in more detail than ever before how the human body’s immune system reacts to malaria and sickle cell disease. The researchers from the universities of Aberdeen, Edinburgh, Exeter and Imperial […].

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.